Participated · Equity · Sep 2025

Post Acute Analytics (PAA) offers Anna, a proprietary, clinically intelligent platform designed to empower care teams and improve outcomes across the post-acute continuum. The software delivers real-time insights that help providers and payers coordinate care, reduce costs and enhance patient outcomes. PAA plans to use newly raised capital to accelerate Anna’s product roadmap and broaden integrations with healthcare partners. The company also intends to deepen collaborations with both existing provider networks and payer organizations. CEO Saqib Akhter says the fresh investment validates PAA’s technology and market strategy. Financial metrics such as revenue or user counts were not disclosed in the article.

Participated · Series C · Sep 2024

Vesta Healthcare operates a virtual care platform that connects patients, family, caregivers, home care agencies, providers, and insurance plans to improve care in the home. Its technology and services span from home-based primary care to passive monitoring and caregiver-enabled clinical workflows. Vesta positions caregivers as an integrated part of the clinical care team to improve outcomes for people with home care needs. The company says it is one of the fastest-growing specialized providers and now serves more than 50,000 people. Vesta recently closed a financing round (Series C) and secured additional debt financing to propel growth. The funding is intended to support continued expansion of its technology and services in the home-care setting. Vesta Healthcare operates a 24/7 clinical provider group and digital health platform centered on its "Homecareist" model, which coordinates in‑home care between patients, paid and unpaid caregivers, and the broader care team. The company delivers telehealth, virtual chronic care management, and remote health monitoring to high‑need, frail senior populations through partnerships with home care agencies, health plans, and providers. Vesta reports that 88% of urgent alerts can be managed and resolved in the home and that its program has driven over a 30% reduction in emergency room visits and hospital admissions. Founded in 2018 and headquartered in New York, Vesta now has a presence in five states and nearly nationwide coverage through its affiliated medical group. The company plans to expand into new geographies, launch new program offerings, broaden partnerships with home care agencies, and take on population health programs and financial risk contracts. The new financing will also fund expansion of Sales, Marketing, Operations, and Technology teams to scale its technology‑enabled caregiver engagement and in‑home clinical programs. Vesta Healthcare (fka HT Health) provides technology and clinical services to support caregivers and link caregiver insights to the rest of the care team. The company proactively identifies needs for additional resources in the home and offers 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to build value-based population health programs emphasizing clinical quality, improved outcomes and personalized engagement. The company is led by CEO Randy Klein and is based in New York City. Vesta closed a $30M Series A to fund growth and plans to use the capital to expand product development, engineering, sales and marketing and to reach new markets.

Led · Series A · Oct 2022

TSOLife offers an AI-driven resident insight and experience platform (Minerva) that converts resident interviews into structured, actionable data to guide real-time decisions in senior living communities. Its platform captures more than 300 data points per resident and claims a 650% improvement over traditional interview methods, enabling deeply personalized engagement, satisfaction tracking, and sales enablement features. TSOLife reports having gathered social and quality-of-life data for over 125,000 residents and partners with major operators including Benchmark Senior Living, Brookdale Senior Living, Sagora Senior Living, Priority Life Care, Senior Resource Group, Vitality Senior Living, and Commonwealth Senior Living. The company says its work strengthens social drivers of health (connection, purpose, engagement) and can extend residents’ length of stay by more than six weeks. TSOLife plans to use recent growth capital to accelerate product development, enhance its AI capabilities, and expand customer support to operationalize personalization across communities. The platform also includes customizable tools such as inclusivity calendars, digital signage, resident and family apps, satisfaction surveys, and real-time analytics to help communities differentiate to prospects. TSOLife provides an AI-based business intelligence platform called Minerva that creates dashboards and personalized tools for senior living staff. The platform uses artificial intelligence to turn prospect and resident knowledge into actionable insights and to accelerate decision-making. TSOLife partners with senior living communities across the nation to deploy Minerva. The company intends to use the Series A proceeds to accelerate development of the Minerva platform. TSOLife is led by CEO David Sawyer. The financing status and use of funds indicate a focus on product development and scaling adoption within the senior living market.

Participated · Equity · Jan 2022

Vynca provides technology and interdisciplinary care teams to support people living with serious illnesses and to improve experiences for patients and caregivers before and during end‑of‑life transitions. The company partners with healthcare providers, payers and risk‑bearing entities to serve populations including those with congestive heart failure, cancer and end‑stage renal disease. Vynca’s solutions aim to enable clinicians and partners to achieve better outcomes while allowing organizations to enter value‑based care arrangements. The firm highlights the scale of need—more than $205B is spent annually in the U.S. during end‑of‑life transitions—and seeks to expand access nationally. With new capital, Vynca plans to grow its clinical services organization and expand its technology suite to meet the needs of value‑based care programs as well as traditional care paradigms. Vynca provides an end-to-end advance care planning solution that helps health care organizations implement and scale advance care planning. Its technology supports education and engagement in advance care planning conversations, shared decision making, digital completion of documents, and ensures universal document accessibility across the care continuum. The company partners with over 80 hospitals, as well as health plans, ACOs, and five state registries. Led by co-founder and CEO Ryan Van Wert, M.D., Vynca plans to use new funding to expand into new geographies and develop new products. The company recently secured $10.3M in Series B financing to support that expansion and product development. The funding and partnerships aim to increase adoption and accessibility of advance care planning across provider networks.

Participated · Series A · Aug 2021

Ellipsis Health is a San Francisco, CA–based AI healthcare technology company that developed Sage, an emotionally intelligent AI voice agent for care management and behavioral health monitoring. Sage is powered by the company’s patented Empathy Engine and is designed to expand provider capacity, streamline workflows, and elevate patient engagement. The company serves leading healthcare providers and payers, focusing on patients with complex physical, behavioral, and social needs that drive the majority of healthcare costs. Ellipsis plans to use new funding to accelerate Sage adoption across healthcare providers, payers, and care management organizations, enhance its AI capabilities, and deepen integration with clinical systems. The company was founded and is led by CEO Mainul Mondal. Financially, Ellipsis has secured a $45M Series A to support these product and go-to-market initiatives. Ellipsis Health, based in San Francisco, develops an AI-powered speech-based vital sign to quantify and manage stress, depression, and anxiety at scale. Its integrated behavioral health solution uses machine-learning algorithms and cloud-based deep learning models to assess patient speech and generate automated assessments for clinical decision support. The company helps healthcare providers and payers identify and stratify patient populations. Ellipsis intends to use the new funding to grow its customer base, expand global partnerships, build a multidisciplinary team, and continue research and development of voice-based technology. It also plans to expand its voice vital sign to address the mental health of children and adolescents. Financially, the company raised a $26M Series A that brought total funding to $31M.